Literature DB >> 6932944

Cloning in vitro and in vivo of Lewis lung carcinoma: properties and characteristics.

G Zupi, F Mauro, A Sacchi.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 6932944      PMCID： PMC2149203     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN： 0306-9443


× No keyword cloud information.
  7 in total

1.  N-methylformamide affects spontaneous metastases of 3LL lines and increases natural killer activity of tumor-bearing mice.

Authors:  C Greco; D Del Bufalo; D Giannarelli; M Marangolo; M P Fuggetta; E Bonmassar; G Zupi
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

2.  Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.

Authors:  T Giraldi; G Sava; R Cherubino; G Bottiroli; G Mazzini
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

3.  Changes of phenotypic characteristics of variants derived from Lewis lung carcinoma during long-term in vitro growth.

Authors:  A Sacchi; F Mauro; G Zupi
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

4.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.

Authors:  V Grill; F Mallardi; S Zorzet; L Perissin; T Giraldi
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

6.  Antitumor activity of Ilmofosine (BM 41.440) in the 3Lewis-lung carcinoma model.

Authors:  D B Herrmann; H G Opitz; P G Munder
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  Effects of prolonged treatment with decarbazine on tumor metastatic potential in mice bearing Lewis lung carcinoma.

Authors:  S Zorzet; L Perissin; V Rapozzi; S Pacor; T Giraldi
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.